Search Results

Filter
  • 1-10 of  37 results for ""Drug Hypersensitivity Syndrome""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Risk factors and drugs associated with the development of drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: A population-based cohort study using the Shizuoka Kokuho database.

Subjects: Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/etiology ; Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/epidemiology ; Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/diagnosis

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Sep; Vol. 91 (3), pp. 573-575. Date of Electronic Publication: 2024 May 23.Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787

Record details

×
Report

Topical versus oral corticosteroids in moderate drug reaction with eosinophilia and systemic symptoms: A multicenter randomized clinical trial.

  • Authors : Ingen-Housz-Oro S; Dermatology Department, Henri Mondor Hospital, AP-HP, Créteil, France; French Investigators for Skin Adverse Reactions to Drugs (FISARD) Group, Paris, France

Subjects: Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/etiology ; Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/diagnosis; Humans

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Sep; Vol. 91 (3), pp. 544-547. Date of Electronic Publication: 2024 May 14.Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787

Record details

×
Editorial & Opinion

Understanding the patient experience of drug reaction with eosinophilia and systemic symptoms: A qualitative study.

  • Authors : Samarakoon U; Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts.

Subjects: Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/etiology ; Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/diagnosis ; Qualitative Research*

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Aug; Vol. 91 (2), pp. 370-373. Date of Electronic Publication: 2024 Apr 26.Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787

Record details

×
Editorial & Opinion

Drug reaction eosinophilia and systemic symptoms: Clinical phenotypic patterns according to causative drug.

  • Authors : Blumenthal KG; Division of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts

Subjects: Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/diagnosis ; Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/etiology ; Phenotype*

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Jun; Vol. 90 (6), pp. 1240-1242. Date of Electronic Publication: 2023 Jun Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787

Record details

×
Editorial & Opinion

Letter from the Editor: Drug reaction with eosinophilia and systemic symptoms syndrome.

  • Authors : Elston DM; Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston, South Carolina. Electronic address: .

Subjects: Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/etiology ; Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/diagnosis; Female

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Jun; Vol. 90 (6), pp. 1153-1154. Date of Electronic Publication: 2023 Jun Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787

Record details

×
Academic Journal

Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis.

  • Authors : Wei BM; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.; Fox LP

Subjects: Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/diagnosis ; Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/epidemiology ; Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/etiology

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 May; Vol. 90 (5), pp. 885-908. Date of Electronic Publication: 2023 Jul 27.Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787

Record details

×
Academic Journal

Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management.

  • Authors : Wei BM; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.; Fox LP

Subjects: Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/diagnosis ; Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/etiology ; Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/therapy

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 May; Vol. 90 (5), pp. 911-926. Date of Electronic Publication: 2023 Jul 28.Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787

Record details

×
Academic Journal

Acute kidney injury in vancomycin-induced drug reaction with eosinophilia and systemic symptoms: A case-control study.

  • Authors : Milani-Nejad N; Division of Dermatology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio. Electronic address: .; Trinidad J

Subjects: Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/diagnosis ; Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/etiology ; Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/drug therapy

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2023 May; Vol. 88 (5), pp. 1121-1123. Date of Electronic Publication: 2020 Sep Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787

Record details

×
Academic Journal

Demographic and laboratory differences seen between acute generalized exanthematous pustulosis and drug reaction with eosinophilia and systemic symptoms: A cross-sectional analysis.

  • Authors : Gallardo MA; College of Medicine, Ohio State University Wexner Medical Center, Columbus, Ohio.; Mallela T

Subjects: Acute Generalized Exanthematous Pustulosis*/Acute Generalized Exanthematous Pustulosis*/Acute Generalized Exanthematous Pustulosis*/diagnosis ; Acute Generalized Exanthematous Pustulosis*/Acute Generalized Exanthematous Pustulosis*/Acute Generalized Exanthematous Pustulosis*/etiology ; Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/diagnosis

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2023 May; Vol. 88 (5), pp. 1142-1145. Date of Electronic Publication: 2022 Nov Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787

Record details

×
Editorial & Opinion

Response to: Momen et al's "Discriminating minor and major forms of drug reaction with eosinophilia and systemic symptoms: Facial edema aligns to the severe phenotype".

  • Authors : Cheng HM; Department of Dermatology, National Skin Centre, Singapore.; Tey HL

Subjects: Angioedema* ; Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/diagnosis ; Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/etiology

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2021 Nov; Vol. 85 (5), pp. e303-e304. Date of Electronic Publication: 2021 Jul Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787

Record details

×
  • 1-10 of  37 results for ""Drug Hypersensitivity Syndrome""